|
|
Other links at Articles > Cardiology |
| 5. |
Disputed Echo Results From MIST I Require Regulatory Attention, Article States
|
|
|
Dr Jonathan Tobis argues that the FDA and the MHRA in the UK should step in to clear up the "mist of confusion" created by the disparate residual-shunt data reported officially and unofficially for MIST I. While the FDA is refusing to comment, the UK agency says it has reviewed the data and found no sign of safety or efficacy problems with the STARflex device. Heartwire
|
|
|
